Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 7-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic Acid
2. Aa 2414
3. Aa-2414
4. Abt-001
1. 112665-43-7
2. Bronica
3. Abbott 73001
4. 7-phenyl-7-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)heptanoic Acid
5. Abt-001
6. Aa-2414
7. Abbott-73001
8. Aa 2414
9. (+-)-7-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic Acid
10. A-73001
11. 103185-78-0
12. Nsc-759640
13. 4u58jm421n
14. Ncgc00181296-01
15. Dsstox_cid_1397
16. Dsstox_rid_76138
17. Dsstox_gsid_21397
18. Seratrodast [usan:inn]
19. Abt 001
20. (+/-)-2,4,5-trimethyl-3,6-dioxo-zeta-phenyl-1,4-cyclohexadiene-1-heptanoic Acid
21. Bronica (tn)
22. Ccris 8939
23. Cas-112665-43-7
24. A 73001
25. Unii-4u58jm421n
26. Seratrodast (jan/usan/inn)
27. 7-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic Acid
28. Seratrodast- Bio-x
29. Seratrodast [mi]
30. Seratrodast [inn]
31. Seratrodast [jan]
32. Seratrodast [usan]
33. (+-)-2,4,5-trimethyl-3,6-dioxo-zeta-phenyl-1,4-cyclohexadiene-1-heptanoic Acid
34. Benzeneheptanoic Acid, Zeta-(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)-, (+-)-
35. Seratrodast [mart.]
36. Schembl98402
37. Seratrodast [who-dd]
38. Mls006012011
39. Dtxsid4021397
40. Chebi:32126
41. Seratrodast, >=98% (hplc)
42. Hms3264k16
43. Hms3748i13
44. Pharmakon1600-01502336
45. Act02647
46. Bcp08860
47. Hy-b0774
48. Tox21_112774
49. Mfcd00875701
50. Nsc759640
51. S2072
52. Stl556121
53. (+/-)-7-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic Acid
54. Akos015911825
55. Seratrodast(aa-2414, Abt-001)
56. Tox21_112774_1
57. Ccg-207903
58. Db06739
59. Nsc 759640
60. 7-phenyl-7-(2,4,5-trimethyl-3,6-dioxo-1-cyclohexa-1,4-dienyl)heptanoic Acid
61. 7-phenyl-7-(2,4,5-trimethyl-3,6-dioxo-cyclohexa-1,4-dien-1-yl)heptanoic Acid
62. Ncgc00181296-02
63. As-12945
64. Bs164397
65. Smr002530529
66. Ft-0631064
67. D01123
68. Ab01563274_01
69. 665s437
70. A802627
71. L001973
72. Sr-01000944172
73. J-002813
74. Q7452735
75. Sr-01000944172-1
76. 6-(6-carboxy-1-phenylhexyl)-2,3,5-trimethylbenzoquinone
77. 7-(3,5,6-trimethyl-1,4-benzoquinone-2-yl)-7-phenylheptanoic Acid
78. 7-phenyl-7-(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadienyl)heptanoic Acid
79. 7-phenyl-7-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)heptanoic Acid
80. (+/-)-2,4,5-trimethyl-3,6-dioxo-.zeta.-phenyl-1,4-cyclohexadiene-1-heptanoic Acid
81. 7-phenyl-7-[2,4,5-trimethyl-3,6-bis(oxidanylidene)cyclohexa-1,4-dien-1-yl]heptanoic Acid
82. Benzeneoctanoic Acid,h-(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)-
83. 103186-19-2
84. Benzeneheptanoic Acid, .zeta.-(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)-, (+/-)-
| Molecular Weight | 354.4 g/mol |
|---|---|
| Molecular Formula | C22H26O4 |
| XLogP3 | 4.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 8 |
| Exact Mass | 354.18310931 g/mol |
| Monoisotopic Mass | 354.18310931 g/mol |
| Topological Polar Surface Area | 71.4 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 633 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Asthmatic Agents
Drugs that are used to treat asthma. (See all compounds classified as Anti-Asthmatic Agents.)
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Prostaglandin Antagonists
Compounds that inhibit the action of prostaglandins. (See all compounds classified as Prostaglandin Antagonists.)
R - Respiratory system
R03 - Drugs for obstructive airway diseases
R03D - Other systemic drugs for obstructive airway diseases
R03DX - Other systemic drugs for obstructive airway diseases
R03DX06 - Seratrodast
Seratrodast has known human metabolites that include (2S,3S,4S,5R)-3,4,5-trihydroxy-6-[7-phenyl-7-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)heptanoyl]oxyoxane-2-carboxylic acid.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
ABOUT THIS PAGE
43
PharmaCompass offers a list of Seratrodast API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Seratrodast manufacturer or Seratrodast supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Seratrodast manufacturer or Seratrodast supplier.
PharmaCompass also assists you with knowing the Seratrodast API Price utilized in the formulation of products. Seratrodast API Price is not always fixed or binding as the Seratrodast Price is obtained through a variety of data sources. The Seratrodast Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Seratrodast manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Seratrodast, including repackagers and relabelers. The FDA regulates Seratrodast manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Seratrodast API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Seratrodast manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Seratrodast supplier is an individual or a company that provides Seratrodast active pharmaceutical ingredient (API) or Seratrodast finished formulations upon request. The Seratrodast suppliers may include Seratrodast API manufacturers, exporters, distributors and traders.
click here to find a list of Seratrodast suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Seratrodast Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Seratrodast GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Seratrodast GMP manufacturer or Seratrodast GMP API supplier for your needs.
A Seratrodast CoA (Certificate of Analysis) is a formal document that attests to Seratrodast's compliance with Seratrodast specifications and serves as a tool for batch-level quality control.
Seratrodast CoA mostly includes findings from lab analyses of a specific batch. For each Seratrodast CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Seratrodast may be tested according to a variety of international standards, such as European Pharmacopoeia (Seratrodast EP), Seratrodast JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Seratrodast USP).
